Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

China Resources Medications Forms $158 Million JV with Pientzehuang

publication date: Nov 10, 2011
China Resources Medications Group will form a one billion RMB ($158 million) joint venture with Zhangzhou Pientzehuang Pharma. China Resources will own 51% of the entity, while Pientzehuang Pharma will be the minority partner. Pientzehuang will contribute eight products to the JV, which plans to build a 200,000 square meters pharmaceutical industrial park in Zhangzhou, Fujian province. More details....

Stock Symbol: (SHA: 600436)     Share this with colleagues:  

 


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital